Daniel J. Smit

Dr. Daniel J. Smit is a Researcher and Head of Research Group at the Institute of Tumor Biology within the Center for Experimental Medicine at the University Medical Center Hamburg-Eppendorf (UKE). His primary affiliation is with the Faculty of Medicine at the University of Hamburg. Holding dual doctoral degrees (Dr. med. and Dr. rer. biol. hum.), he specializes in oncology, molecular biology, and translational research. His work focuses on liquid biopsy technologies, circulating tumor cells (CTCs), metastasis mechanisms, and immunotherapy efficacy.

Research Interests: Dr. Smit’s research bridges basic science and clinical application, emphasizing the development of non-invasive diagnostic tools for cancer (e.g., liquid biopsy markers), understanding tumor cell plasticity, and optimizing therapeutic strategies targeting signaling pathways like AKT/mTOR. He has pioneered studies on CTC clusters, biomarker validation in melanoma, and anticoagulant-therapy interactions in cancer patients.

Awards: In 2023, he was honored as Teacher of the Year by the University of Hamburg Medical Faculty and received the Young Investigator Award from the European Liquid Biopsy Society.

Advising & Grants: While specific grant details aren’t listed, his publications suggest active involvement in multicenter trials (e.g., ADOReg registry) and collaborations with institutions like the European Liquid Biopsy Society. His lab focuses on translational oncology, aiming to bridge preclinical findings with clinical practice.

Labs/Teams: Leads a research group at the Institute of Tumor Biology, collaborating with international teams on projects involving liquid biopsy standardization and metastasis biology.